Satter Muneer A

CIK 00013157979 companiesBRISBANE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001315797

Recent Transactions

50 trades

Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2026-06-11+65,000→ 65,000 total
Purchase
Annexon, Inc.$ANNX
Common Stock
2026-05-28$5.41/sh+613,497→ 10,342,134 total
Purchase
Annexon, Inc.$ANNX
Common Stock
2025-11-21$4.28/sh+422,613→ 9,728,637 total
Purchase
Annexon, Inc.$ANNX
Common Stock
2025-11-20$4.48/sh+400,000→ 9,306,024 total
Purchase
Annexon, Inc.$ANNX
Common Stock
2025-11-19$3.94/sh+500,000→ 8,906,024 total
Purchase
Annexon, Inc.$ANNX
Common Stock
2025-11-18$3.18/sh+500,000→ 8,406,024 total
Purchase
Annexon, Inc.$ANNX
Common Stock
2025-11-17$2.99/sh+500,000→ 7,906,024 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2025-06-05+55,000→ 55,000 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2024-06-05+44,000→ 44,000 total
Purchase
Annexon, Inc.$ANNX
Common Stock
2023-12-26$2.88/sh+350,000→ 7,406,024 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2023-06-08+24,000→ 24,000 total
Purchase
Annexon, Inc.$ANNX
Common Stock
2023-02-10$6.80/sh+2,647,058→ 7,056,024 total
Purchase
Annexon, Inc.$ANNX
Common Stock
2022-07-07$3.84/sh+2,453,988→ 4,408,966 total
Purchase
Annexon, Inc.$ANNX
Warrants (Right to Buy)
2022-07-07$0.13/sh+613,497→ 613,497 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2022-06-09+24,000→ 24,000 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2021-06-02+10,000→ 10,000 total
Purchase
Rein Therapeutics, Inc.$RNTX
Common Stock
2021-01-08$1.10/sh+9,000,000→ 16,609,449 total
Conversion
Annexon, Inc.$ANNX
Series C Preferred Stock
2020-07-28−5,537,036→ 0 total
Conversion
Annexon, Inc.$ANNX
Series A-1 Preferred Stock
2020-07-28−3,095,238→ 0 total
Purchase
Annexon, Inc.$ANNX
Common Stock
2020-07-28$17.00/sh+200,000→ 1,954,978 total
Conversion
Annexon, Inc.$ANNX
Series D Preferred Stock
2020-07-28−2,812,543→ 0 total
Conversion
Annexon, Inc.$ANNX
Series B Preferred Stock
2020-07-28−4,016,573→ 0 total
Conversion
Annexon, Inc.$ANNX
Common Stock
2020-07-28+1,754,978→ 1,754,978 total
Purchase
Rein Therapeutics, Inc.$RNTX
Common Stock
2020-06-08$1.10/sh+3,700,000→ 7,609,449 total
Award
Whitehawk Therapeutics, Inc.$WHWK
Stock Option (Right to Buy)
2019-06-18+21,400→ 21,400 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2019-01-10$2.45/sh+23,818→ 5,621,835 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2019-01-09$2.39/sh+20,000→ 5,598,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2019-01-08$2.20/sh+20,000→ 5,578,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2019-01-07$2.18/sh+20,000→ 5,558,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2019-01-04$2.12/sh+20,000→ 5,538,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2019-01-03$2.08/sh+20,000→ 5,518,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2019-01-02$1.94/sh+20,000→ 5,498,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2018-12-31$1.75/sh+20,000→ 5,478,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2018-12-28$1.72/sh+20,000→ 5,458,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2018-12-27$1.67/sh+20,000→ 5,438,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2018-12-26$1.69/sh+20,000→ 5,418,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2018-12-21$1.84/sh+20,000→ 5,398,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2018-12-20$1.85/sh+20,000→ 5,378,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2018-12-19$1.92/sh+20,000→ 5,358,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2018-12-18$1.99/sh+20,000→ 5,338,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2018-12-14$2.00/sh+20,000→ 5,318,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2018-12-13$2.02/sh+20,000→ 5,298,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2018-12-12$2.05/sh+20,000→ 5,278,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2018-12-11$2.09/sh+20,000→ 5,258,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2018-12-10$2.13/sh+20,000→ 5,238,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2018-12-07$2.14/sh+20,000→ 5,218,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2018-12-06$2.18/sh+20,000→ 5,198,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2018-12-04$2.10/sh+20,000→ 5,178,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2018-12-03$1.99/sh+20,000→ 5,158,017 total
Purchase
Whitehawk Therapeutics, Inc.$WHWK
Common Stock
2018-11-30$1.98/sh+20,000→ 5,138,017 total

Companies

Recent Filings

Address

C/O ANNEXON, INC. 1400 SIERRA POINT PKWY, BLDG C, STE 200

BRISBANE, CA, 94005

View on SEC.gov